Phase II study for Zydena successfully completed in U. S.
Dong-A PharmTec, a subsidiary of Dong-A playing a major role for the overseas clinical studies, said recently that the company conducted the phas...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
